Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT05768932 ×

NCT05768932

This funder is selected. Its supporting articles are shown below.

NCT057689321

Articles mentioning NCT05768932

1 articles · page 1 of 1

621 Optimizing immunomodulation of BAL0891, a TTK/PLK1 dual Inhibitor, to enhance synergy with immune checkpoint blockade using a biomimetic tumor microenvironment platform and pharmacometric modeling

jitc · abstract · 2025-11-04 · 1 matching annotations

80.2%

NCT05768932 BAL0891 pembrolizumab Cancer Research 2025 triple-negative breast cancer

…rs derived from the ongoing Phase I clinical trial (TTK-CS-101, NCT05768932) were integrated to simulate and identify optimal dosing regime…